Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis

Cited by (1,001)

Items 801–900 of 1,001

1. The Effects of Urinary Albumin and Hypertension on All-Cause and Cardiovascular Disease Mortality in Korea
   Mi Hae Seo, Jong‐Young Lee, Seungho Ryu, Yu Sam Won, Ki‐Chul Sung · 2017 · American Journal of Hypertension
2. Enfermedad renal crónica en individuos hipertensos ≥60 años atendidos en Atención Primaria
   Betlem Salvador-González, Jordi Mestre-Ferrer, Maria Soler-Vila, Luisa Pascual-Benito, Eva Alonso-Bes, Oriol Cunillera · 2017 · Nefrología
3. Vitamin D and omega-3 trial to prevent and treat diabetic kidney disease: Rationale, design, and baseline characteristics
   Ian H. de Boer, Leila R. Zelnick, Julie Lin, Debra Ann Schaumberg, Lu Wang, JOHN T. RUZINSKI, Georgina Friedenberg, Julie Duszlak, Vadim Y. Bubes, Andrew N. Hoofnagle et al. · 2018 · Contemporary Clinical Trials
4. Crescents formations are independently associated with higher mortality in biopsy-confirmed immunoglobulin A nephropathy
   Cheng‐Hsu Chen, Ming‐Ju Wu, Mei‐Chin Wen, Shang-Feng Tsai · 2020 · PLoS ONE
5. Sex Differences in Fecal Microbiota Correlation With Physiological and Biochemical Indices Associated With End-Stage Renal Disease Caused by Immunoglobulin a Nephropathy or Diabetes
   Peng Zhang, Jiali Fang, Guanghui Li, Lei Zhang, Xingqiang Lai, Lu Xu, Luhao Liu, Yunyi Xiong, Li Li, Tao Zhang et al. · 2021 · Frontiers in Microbiology
6. Rationale and study design of a randomized controlled trial to assess the effects of maintaining hemoglobin levels using darbepoetin alfa on prevention of development of end-stage kidney disease in non-diabetic CKD patients (PREDICT Trial)
   Enyu Imai, Shoichi Maruyama, Masaomi Nangaku, Hideki Hirakata, Terumasa Hayashi, Ichiei Narita, Hideki Kono, Eiji Nakatani, Satoshi Morita, Yoshiharu Tsubakihara et al. · 2015 · Clinical and Experimental Nephrology
7. Epidemiology of Chronic Kidney Disease—Scope of the Problem
   Mark Canney, Peter Birks, Adeera Levin · 2019 · Elsevier eBooks
8. Albuminuria Increases All-Cause Mortality in Japanese Patients with Type 2 Diabetes Mellitus
   Hitomi Miyake, Ippei Kanazawa, Toshitsugu Sugimoto · 2018 · Journal of Clinical Medicine
9. Kidney function trajectories, associated factors, and outcomes in multiethnic Asian patients with type 2 diabetes
   Liang Feng, Yong Mong Bee, Xiuju Fu, Jia Liang Kwek, Choong Meng Chan, Tazeen H. Jafar · 2024 · Journal of Diabetes
10. Effects of melatonin supplementation on oxidative stress, and inflammatory biomarkers in diabetic patients with chronic kidney disease: a double-blind, randomized controlled trial
    Sara Sadeghi, Amir Ahmad Nassiri, Monir Sadat Hakemi, Fatemeh Sadat Hosseini, Fatemeh Pourrezagholie, Fatemeh Naeini, Aylar Nadiri Niri, Hossein Imani, Hamed Mohammadi · 2025 · BMC Nutrition
11. Relationships Between Retinal Vascular Characteristics and Systemic Indicators in Patients With Diabetes Mellitus
    Xingyu Xiao, Jianchun Zhao, Shiqun Lin, Yajie Yang, Wenhui Li, Yan Zhou, Xiao Chi Zhang, Rongping Dai · 2025 · Investigative Ophthalmology & Visual Science
12. Association of chronic kidney disease and cardiovascular disease risk with all-cause mortality: an interaction, joint and mediation analysis in Chinese adults
    Yang Li, Yiqin Shi, Bowen Zhu, Yafei Chen, Bo Shen, Shuan Zhao, Nana Song, Yi Fang, Xiaoqiang Ding · 2025 · BMC Public Health
13. Real-World Effectiveness of Finerenone Added to SGLT2 Inhibitor and GLP-1 Receptor Agonist Therapy in Individuals with Type 2 Diabetes and Chronic Kidney Disease
    Afif Nakhleh, Khaled Khazim, Naim Shehadeh · 2025 · Journal of Clinical Medicine
14. Modern Management of CKM Syndrome: Use of GLP-1 Receptor Agonists in a Multidisciplinary Setting—Expert Group Recommendations from Kuwait
    Waleed A. Al-Dahi, Abdullah Alenezi, Thamer Alessa, Rashed Alhamdan, Khaldoon Al-Humood, Ahmed Alqallaf, Torki M AlOtaibi, Heba AlRajab, Abdulmuhsen M. Alshammari, Anas Alyousef et al. · 2026 · Diabetes Therapy
15. Efficacy of traditional Chinese medicine injection for diabetic kidney disease: A network meta analysis and systematic review
    Caiyi Long, Haoyue Feng, Zheng Liu, Zihan Li, Jun Liu, Yayi Jiang, Rensong Yue · 2023 · Frontiers in Pharmacology
16. Incorporating Evidence and Guidelines for Personalized Care of Diabetes and Chronic Kidney Disease
    Joshua J. Neumiller, Radica Z. Alicic, Katherine R. Tuttle · 2023 · Seminars in Nephrology
17. Evaluation of the Effect of an α-Adrenergic Blocker, a PPAR-γ Receptor Agonist, and a Glycemic Regulator on Chronic Kidney Disease in Diabetic Rats
    Jorge Christopher Morones-Gamboa, Mariana Pérez, Martín Humberto Muñoz‐Ortega, Esperanza Sánchez, Manuel Enrique Ávila‐Blanco, Jorge Fernando Topete-Reyes, Javier Ventura‐Juárez, Sandra Luz Martínez-Hernández · 2024 · International Journal of Molecular Sciences
18. To live with normal GFR: when higher is not better
    Nicolas Rognant, Maurice Laville · 2014 · Kidney International
19. Investigation of apparent non-albuminuric proteinuria in a primary care population
    Malcolm P. McTaggart, Paul E. Stevens, Christopher P. Price, Ronald G. Newall, Roger G. Pinnock, Edmund J. Lamb · 2013 · Clinical Chemistry and Laboratory Medicine (CCLM)
20. Biomarkers of Cardiovascular Risk in Chronic Kidney Disease
    Zoltan Huba Endre, Robert James Walker · 2016 · Elsevier eBooks
21. Comprehensive risk management of diabetic kidney disease in patients with type 2 diabetes mellitus
    Shin‐ichi Araki · 2018 · Diabetology International
22. Increased Urinary Liver-Type Fatty Acid-Binding Protein Level Predicts Major Adverse Cardiovascular Events in Patients With Hypertension
    Yousaku Okubo, Yukiko Nakano, Takehito Tokuyama, Naoya Hironobe, Sho Okamura, Yoshihiro Ikeuchi, Shunsuke Miyauchi, Yasuki Kihara · 2020 · American Journal of Hypertension
23. Alternative kidney filtration markers and the risk of major macrovascular and microvascular events, and all‐cause mortality in individuals with type 2 diabetes in the ADVANCE trial
    Hyunju Kim, Dan Wang, John Philip Chalmers, Min Jun, Sophia Zoungas, Michel Marre, Pavel Hamet, Stephen B. Harrap, Giuseppe Mancia, Neil R Poulter et al. · 2020 · Journal of Diabetes
24. A Comprehensive Cardiovascular-Renal-Metabolic Risk Reduction Approach to Patients with Type 2 Diabetes Mellitus
    Neha Jadeja Pagidipati, PRAKASH C. DEEDWANIA · 2021 · The American Journal of Medicine
25. Primary Prevention of CVD with Aspirin: Benefits vs Risks
    Weisman · 2021 · The Journal of Family Practice
26. Validation of the kidney failure risk equation in a Portuguese cohort
    Bernardo Marques da Silva, José Charreu, Inês Duarte, Cristina Outerelo, Joana Gameiro · 2022 · Nefrología
27. Geographical variation in kidney function testing and associations with health care costs among patients with chronic kidney disease and type 2 diabetes
    Keith A. Betts · 2022 · The American Journal of Managed Care
28. Healthcare costs associated with comorbid cardiovascular and renal conditions among persons with diabetes, 2008–2019
    Chintal H. Shah, Chintan V. Dave · 2022 · Diabetology & Metabolic Syndrome
29. Factors Associated with the Antihypertensive Effect of Esaxerenone and Serum Potassium Elevation: A Pooled Analysis of Seven Phase III Studies
    Sadayoshi Ito, Yasuyuki Okuda, Kotaro Sugimoto · 2023 · Advances in Therapy
30. Association of kidney disease index with all‐cause and cardiovascular mortality among individuals with hypertension
    Suxia Fang, Yuwen Chen, Qiyue Gao, Qucheng Wei · 2023 · Clinical Cardiology
31. Has the time come for age-adapted glomerular filtration rate criteria to define chronic kidney disease: how soon is now?
    Gregory L. Hundemer, Ayub Akbari, Manish M. Sood · 2024 · Current Opinion in Nephrology & Hypertension
32. Olmesartan vs ramipril in the treatment of hypertension and associated clinical conditions in the elderly: a reanalysis of two large double blind, randomized studies at the light of the most recent blood pressure targets recommended by guidelines
    Stefano Omboni, Ettore Malacco, Jean-Michel Mallion, Massimo Volpe · 2015 · Clinical Interventions in Aging
33. Diabetic kidney disease and vascular comorbidities in patients with type 2 diabetes mellitus in a developing country
    Yassamine Bentata, Abdeljalil Chemlal, I Karimi, F. El Alaoui, I. Haddiya, Rédouane Abouqal · 2015 · Saudi Journal of Kidney Diseases and Transplantation
34. Identification of the Stages of Diabetic Nephropathy at Which Angiotensin II Receptor Blockers Most Effectively Suppress Albuminuria
    Susumu Ogawa, Masato Matsushima, Takefumi Mori, Masashi Okamura, Miho Senda, Takuya Sakamoto, Kazuhiro Nako, Sadayoshi Ito · 2013 · American Journal of Hypertension
35. Blood pressure targets in chronic kidney disease: Does proteinuria dictate how low we go?
    Ainslie M. Hildebrand, Amit X. Garg · 2013 · Canadian Medical Association Journal
36. Proteinuria reaffirmed as a risk modifier in diabetic chronic kidney disease
    Gary C.W. Chan, Sydney C.W. Tang · 2018 · Nephrology Dialysis Transplantation
37. Chronic kidney disease in type 2 diabetes: Does an abnormal urine albumin-to-creatinine ratio need to be retested?
    Divya Garg, Christopher T Naugler, Vishal S Bhella, Fahmida Yeasmin · 2018 · Europe PMC (PubMed Central)
38. 2021 Asian Pacific Society of Cardiology Consensus Recommendations on the Use of P2Y12 Receptor Antagonists in the Asia-Pacific Region: Special Populations
    Jack Wei Chieh Tan, Derek P. Chew, Kin Lam Tsui, Doreen Su‐Yin Tan, Dmitry Viktorovich Duplyakov, Ayman Jaber Hammoudeh, Bo Zhang, Yi Li, Kai Xu, Paul Jau Lueng Ong et al. · 2021 · European Cardiology Review
39. Risk Factors of End Stage Renal Disease in Peshawar, Pakistan: Odds Ratio Analysis
    Salahuddin Khan, Tariq A. Hussain, Najma Salahuddin, Salahuddin Mehreen · 2016 · Open Access Macedonian Journal of Medical Sciences
40. Chronic kidney disease in hypertensive subjects ≥60 years treated in Primary Care
    Betlem Salvador-González, Jordi Mestre-Ferrer, Maria Soler-Vila, Luisa Pascual-Benito, Eva Alonso-Bes, Oriol Cunillera · 2017 · Nefrología (English Edition)
41. Kidney Disease in Diabetes
    2020 · Diabetes : current and future developments
42. Glucose-Lowering Drugs to Reduce Cardiovascular Risk in Type 2 Diabetes
    Silvio E Inzucchi, Aldo J Peixoto, Jeffrey M Testani · 2021 · New England Journal of Medicine
43. Correction of Vascular Calcification and Hyperphosphatemia in CKD Rats Treated with ASARM Peptide
    Peter S. Rowe, Ellen M. McCarthy, Alan S.L. Yu, Jason R. Stubbs · 2022 · Kidney360
44. MicroRNAs associated with chronic kidney disease in the general population and high-risk subgroups: protocol for a systematic review and meta-analysis
    Dipuo D. Motshwari, Don Makwakiwe Matshazi, Rajiv Timothy Erasmus, André Pascal Kengne, Tandi Edith Matsha, Cindy George · 2022 · BMJ Open
45. The progression from mild to severe hyperglycemia coupled with insulin resistance causes mitochondrial dysfunction and alters the metabolic secretome of epithelial kidney cells
    Patrícia C. Braga, Raquel L. Bernardino, Bárbara Guerra‐Carvalho, David F. Carrageta, Pedro Fontes Oliveira, Anabela S. Rodrigues, Marco Gouveia Alves · 2023 · Experimental Cell Research
46. Prognostic Impact of Renal Function on 5‐Year Outcomes After Fractional Flow Reserve‐Guided Deferral of Revascularization
    Ryosuke Itakura, Shoichi Kuramitsu, Jun Kikuchi, Yoshiaki Kawase, Takuya Mizukami, Tomohiro Shinozaki, Kazunori Horie, Hiroaki Takashima, Hidenobu Terai, Yuetsu Kikuta et al. · 2023 · Journal of the American Heart Association
47. Cardiac Effects of Renin-Angiotensin System Inhibitors in Nonproteinuric CKD
    Rachel S. Shulman, Wei Peter Yang, Debbie L. Cohen, Peter Philip Reese, Jordana B. Cohen, the CRIC Study Investigators · 2024 · Hypertension
48. Elevated circulating homocysteine concentrations delayed nerve conduction velocity and increase the risk of diabetic kidney disease in patients with type 2 diabetes
    Nannan Lv, Luzhu Jia, Fei Liu, Lan Cheng, Feng Liu, Jinsong Kuang, Xin Chen · 2024 · Frontiers in Endocrinology
49. Prevalence and Predictors of Silent Myocardial Ischemia in Diabetic Patients
    Hafiz Abdul Manan, Hammad Rauf Chishti, Franklin Dzigbodi Hewlett · 2025 · Cureus
50. Curcumin and its novel formulations for diabetes mellitus and its complications: a review
    Xiaoqin Liu, Qingzhi Liang, Wei Jiang, Jianlong J. Zhou, Chunying Liu, Ling Deng, Haoyue Feng, Rensong Yue · 2025 · Food & Function
51. Baseline Kidney Function, Albuminuria, and Urine Albumin-Creatinine Ratio Reduction with Finerenone, Empagliflozin, or Both
    Amy K. Mottl, Charlie A. B. Scott, Jennifer B. Green, Hiddo J.L. Heerspink, Johannes F.E. Mann, Janet B. McGill, Masaomi Nangaku, Julio Rosenstock, Peter R Rossing, Li Li et al. · 2025 · Journal of the American Society of Nephrology
52. The gut as a central hub for multi-organ crosstalk in aging
    Xianhong Zhang, Rongqing Li, Yue Gao, Wenjia Zhang, Ting Ni, Yongbin Liu · 2026 · Cellular and Molecular Life Sciences
53. 1308 PARTIAL NEPHRECTOMY FOR THE TREATMENT OF RENAL CELL CARCINOMA AND THE RISK OF END STAGE RENAL DISEASE
    Stanley A. Yap, Shabbir M.H. Alibhai, GEORGE A. TOMLINSON, David Robert Urbach, Antonio Finelli · 2013 · The Journal of Urology
54. A study to assess the associated risk of developing cardiovascular diseases in chronic kidney disease
    Bujagouni Swapna, Kaneez Fathima, Hifsa Muwayyad, Madeeha Khanam, S Salma, Surabhi Harsha, Numair Gayas · 2024 · Cellular Molecular and Biomedical Reports
55. Primary care clinician perspectives on automated nephrology e-consults for diabetic kidney disease: a pre-implementation qualitative study
    Chi D. Chu, Daniel Paul Dohan, Michelle M. Estrella, Michael G. Shlipak, Delphine S. Tuot · 2024 · BMC Family Practice
56. Integrating multiple kidney function markers to predict all-cause and cardiovascular disease mortality: prospective analysis of 366 758 UK Biobank participants
    Ryosuke Fujii, Roberto Melotti, Anna Köttgen, Alexander Teumer, Daniele Giardiello, Cristian Pattaro · 2024 · Clinical Kidney Journal
57. Cardiac Biomarkers Predict Major Adverse Cardiac Events (MACE) in Incident Haemodialysis Patients: Results from a Global Federated Database
    Elin Mitford Davies, Benjamin J. R. Buckley, Philip J. Austin, Gregory Y.H. Lip, Anirudh Rao, Garry McDowell · 2025 · Biomedicines
58. The Role of Mesenchymal Stem Cells in Treating Diabetic Kidney Disease: Immunomodulatory Effects and Kidney Regeneration
    Po-Jen Hsiao, Wen-Yi Kao, Li‐Chin Sung, Chia-Yi Lin, Liam Li-An Tsou, Yung-Hsi Kao, Chu‐Lin Chou, Kung-Ta Lee · 2025 · International Journal of Medical Sciences
59. Control of hypertension and survival in haemodialysis patients
    Kunitoshi Iseki · 2014 · Nephrology
60. Diabetic Kidney Disease: Much Progress, But Still More to Do
    Mark E. Molitch · 2015 · Diabetes Spectrum
61. Evolution of target organ damage and haemodynamic parameters over 4 years in patients with increased insulin resistance: the LOD-DIABETES prospective observational study
    Manuel Ángel Gómez-Marcos, Jose Ignacio Recio-Rodriguez, María Carmen Patino-Alonso, Cristina Agudo‐Conde, Emiliano Rodríguez‐Sánchez, José Ángel Maderuelo-Fernández, Leticia Gómez‐Sánchez, Marta Gómez‐Sánchez, Luis García‐Ortiz, LOD-DIABETES Group · 2016 · BMJ Open
62. N-Acetyl-seryl-aspartyl-lysyl-proline is a potential biomarker of renal function in normoalbuminuric diabetic patients with eGFR ≥ 30 ml/min/1.73 m2
    Kyoko Nitta, Takako Nagai, Yuiko Mizunuma, Munehiro Kitada, Atsushi Nakagawa, Masaru Sakurai, Masao Toyoda, Masakazu Haneda, Keizo Kanasaki, Daisuke Koya · 2019 · Clinical and Experimental Nephrology
63. Creating a 13-year National Longitudinal Cohort of veterans with chronic kidney disease
    Mukoso N. Ozieh, Mulugeta Gebregziabher, Ralph C Ward, David James Taber, Leonard E. Egede · 2019 · BMC Nephrology
64. Decreased glomerular filtration rate in patients with at least 5 years of type 2 diabetes in Ho Chi Minh City, Vietnam: Prevalence and associated factors
    Hoa Tuyet Le, Tung Thanh Le, Nguyet Minh Thi Tran, Thuy Thanh Thi Nguyen, Ni Chanh Su Minh, Quyen Thi Le, Tuyet Anh Thi Tram, Thang Duc Tran, Tung Xuan Doan, Truc Thanh Thai · 2019 · Primary care diabetes
65. Cardiovascular rEmodelling in living kidNey donorS with reduced glomerular filtration rate: rationale and design of the CENS study
    Kjersti B. Blom, Kaja Knudsen Bergo, Emil Knut Stenersen Espe, Vigdis Rosseland, Ole Jørgen Grøtta, Geir Mjøen, Anders Åsberg, Stein Bergan, Helga Sanner, Tone Kristin Bergersen et al. · 2019 · Blood Pressure
66. COVID-19 and kidneys
    Минара Шамхаловна Шамхалова, Natalia G. Mokrysheva, Marina Vladimirovna Shestakova · 2020 · Diabetes Mellitus
67. Effects of Alpha-lipoic Acid Supplementation on Human Diabetic Nephropathy: A Systematic Review and Meta-analysis
    Elena Vakali, Dimitrios Rigopoulos, Andres E. Carrillo, Andreas D. Flouris, Petros C. Dinas · 2021 · Current Diabetes Reviews
68. Intravitreal Vascular Endothelial Growth Factor Inhibitor Use and Renal Function Decline in Patients with Diabetic Retinopathy
    Shih‐Hsiang Ou, Chun-Hao Yin, Tung‐Ling Chung, Hsin‐Yu Chen, Chien‐Liang Chen, Jin‐Shuen Chen, Po‐Tsang Lee · 2022 · International Journal of Environmental Research and Public Health
69. Comparison of survival rates between incident hemodialysis patients and peritoneal dialysis patients: a 5-year prospective cohort study with propensity score matching
    Mami Miyazaki, Kensuke Sasaki, Ayumu Nakashima, Akira Takahashi, Naoki Ishiuchi, Ryo Tamura, Yosuke Osaki, Shigehiro Doi, Takao Masaki · 2023 · Clinical and Experimental Nephrology
70. Interpreting an estimated glomerular filtration rate (eGFR) in people of black ethnicities in the UK
    Kathryn Griffiths, Rouvick Mariano Gama, June Fabian, Mariam Molokhia · 2023 · BMJ
71. Use of Analog and Human Insulin in a European Hemodialysis Cohort With Type 2 Diabetes: Associations With Mortality, Hospitalization, MACE, and Hypoglycemia
    Thomas Ebert, Nosheen Sattar, Marni Greig, Claudia Lamina, Marc Froissart, Kai‐Uwe Eckardt, Jürgen Floege, Florian Kronenberg, Peter Stenvinkel, David Collins. Wheeler et al. · 2023 · American Journal of Kidney Diseases
72. Comparisons of clinical outcomes between hypertensive and normotensive living kidney donors: a prospective, multicenter nationwide cohort study
    Jong Ho Kim, Yu Ho Lee, Dae Kyu Kim, Jin Sug Kim, Kyung Hwan Jeong, Ku Yong Chung, Jong Cheol Jeong, Soo Jin Na Choi, Jaeseok Yang, Myoung Soo Kim et al. · 2025 · Kidney Research and Clinical Practice
73. NT-proBNP Linking Low-Moderately Impaired Renal Function and Cardiovascular Mortality in Diabetic Patients: The Population-Based Casale Monferrato Study
    Graziella Bruno, Federica Barutta, Andrea Landi, Paolo Cavallo Perin, Gabriella Gruden · 2014 · PLoS ONE
74. Elevation of Non-Classical (CD14+/lowCD16++) Monocytes Is Associated with Increased Albuminuria and Urine TGF-β1 in HIV-Infected Individuals on Stable Antiretroviral Therapy
    Brooks I. Mitchell, Mary Margaret Byron, Roland C.K. Ng, Dominic Cheung Chow, Lishomwa C. Ndhlovu, Cecilia M. Shikuma · 2016 · PLoS ONE
75. Survival rates and worker compensation expenses in a national cohort of Mexican workers with permanent occupational disability caused by diabetes
    Iván de Jesús Ascencio-Montiel, J Kumate-Rodríguez, Víctor Hugo Borja‐Aburto, José Esteban Fernández-Gárate, Selene Konik-Comonfort, Oliver Macías-Pérez, Ángel el Campos-Hernández, Héctor or Rodríguez-Vázquez, Verónica Miriam López-Roldán, Edgar Jesús Zitle-García et al. · 2016 · BMC Public Health
76. Different associations of albuminuria with total and cardiovascular mortality by concentrations of persistent organic pollutants in the elderly
    Hyun‐Woo Kim, Jung-Hyun Kim, Dong-Won Lee, Sang‐Hyun Cho, Ji‐hoon Jung, Ki-Su Kim, Duk-Hee Lee · 2017 · Environmental Research
77. Community burden and prognostic impact of reduced kidney function among patients hospitalized with acute decompensated heart failure: The Atherosclerosis Risk in Communities (ARIC) Study Community Surveillance
    Kunihiro Matsushita, Lucia Kwak, Noorie Hyun, Marina Bessel, Sunil Kumar Agarwal, Laura R. Loehr, Hanyu Ni, Patricia P. Chang, Josef Coresh, Lisa Miller Wruck et al. · 2017 · PLoS ONE
78. Risk-Stratified Incidence of Renal Replacement Therapy Initiation: A Longitudinal Analysis Using Medical Claims and Health Checkup Data
    Takehiro Sugiyama, Koji Oba, Yasuki Kobayashi · 2019 · The Tohoku Journal of Experimental Medicine
79. Albuminuria and other target organ damage in Chinese patients with hypertension and diabetes: A data analysis based on the ATTEND study
    Qian Ren, Changsheng Ma, Ji‐Guang Wang, Xiaohui Guo, Linong Ji · 2019 · Journal of Diabetes and its Complications
80. Physicians’ Recognition and Management of Kidney Disease: A Randomized Vignette Study Evaluating the Impact of the KDIGO 2012 CKD Classification System
    Stein Ivar Hallan, Dena E. Rifkin, Onur Potok, Knut Asbjørn Rise Langlo, Friedo Wilhelm Dekker, Joachim H. Ix · 2020 · Kidney Medicine
81. Type 2 diabetes and cardiorenal syndromes. A nationwide French hospital cohort study
    Valentin Maisons, Jean‐Michel Halimi, Grégoire Fauchier, Jean-Baptiste de Fréminville, Nicolas Goin, Juliette Gueguen, Philippe Gatault, Bénédicte Sautenet, Denis Angoulvant, Julien Herbert et al. · 2023 · Diabetes & Metabolism
82. Accelerated decline of renal function in type 2 diabetes following severe hypoglycemia
    Tetsuro Tsujimoto, Ritsuko Yamamoto‐Honda, Hiroshi Kajio, Miyako Kishimoto, Hiroshi Noto, Remi Hachiya, Akio Kimura, Masafumi Kakei, Mitsuhiko Noda · 2016 · Journal of Diabetes and its Complications
83. The effects of AER and eGFR on outcomes of CVD in patients with T2DM in an urban community over 8 years of multifactorial treatment: the Beijing Communities Diabetes Study 18
    Xuelian Zhang, Mingxia Yuan, Gang Wan, Guang-Ran Yang, Dongmei Li, Han-Jing Fu, Liangxiang Zhu, Rong-Rong Xie, Jian-Dong Zhang, Yujie Lv et al. · 2018 · Therapeutics and Clinical Risk Management
84. Epidemiology and Public Health
    Elizabeth J. Mayer‐Davis, DARIA A. IGUDESMAN · 2022
85. Therapeutic strategies for type 2 diabetes mellitus patients with very high HbA1c: is insulin the only option?
    Muhammad A Abdul‐Ghani, Ralph A. DeFronzo · 2018 · Annals of Translational Medicine
86. Association of plasma ceramide with decline in kidney function in patients with type 2 diabetes
    Resham L Gurung, M Yiamunaa, Wai Kin Tham, Sylvia Liu, Huili Zheng, Janus Lee, Keven Ang, Markus Rene Wenk, Tavintharan Subramaniam, Chee Fang Sum et al. · 2024 · Journal of Lipid Research
87. A novel index evaluating left atrioventricular coupling function in chronic kidney disease with diabetes patients
    Xue Min Gao, Aihua Xie, Weiwei Xiao, Liqin Ji, Houyu Li, Anlingzi Zou, Zhuomeng Miao, Xinru Zhang, Siyuan Yang, Shaomei Yu · 2025 · Scientific Reports
88. Risk factors for peripheral arterial disease in type 2 diabetes mellitus patients: A systematic review and meta-analysis
    Martha Rosana, Em Yunir, Ninik Saragih, Lusiani Rusdi, Dyah Purnamasari, Tri Juli Edi Tarigan, Dicky L. Tahapary, Pradana Soewondo · 2025 · Diabetes Research and Clinical Practice
89. Impact of type 2 diabetes on the relationship between chronic kidney disease and cardiovascular outcomes in heart failure across ejection fraction: observational study from the Swedish heart failure and the Swedish National diabetes registries
    Aurora Merolla, Valeria Valente, Christian Basile, Lina Benson, Francesco Cosentino, Ulf Dahlström, Soffia Guðbjörnsdóttir, Patrizia Querini Rovere, Lars H Lund, Gianluigi Savarese et al. · 2025 · Cardiovascular Diabetology
90. Missing Opportunity for Nephroprotective Therapy in Patients With Non-Dialysis CKD Under Stable Nephrology Care
    Luca De Nicola, Chiara Ruotolo, Gaetano La Manna, Vincenzo Bellizzi, Loreto Gesualdo, Felice Nappi, Pietro Manuel Ferraro, Carmelita Marcantoni, Domenico Santoro, Giovanni Stallone et al. · 2026 · Kidney International Reports
91. Long-term outcomes of stereotactic ablative body radiotherapy for primary kidney cancer (TROG 15.03 FASTRACK II): a multicentre, non-randomised, phase 2 study
    Shankar Siva, David I. Pryor, Jarad M. Martin, Nicholas Hardcastle, Daniel Moon, Tomas Kron, Braden Higgs, Farshad Foroudi, Jeremy Ruben, Swetha Sridharan et al. · 2026 · The Lancet Oncology
92. Ultra-hypofractionated stereotactic ablative body radiotherapy for primary renal cell carcinoma: 5-year outcomes from a pooled analysis of the FASTRACK trials
    Shankar Siva, Muhammad Ali, Nicholas Hardcastle, Tomas Kron, Braden Higgs, Farshad Foroudi, Jeremy Ruben, Sree Appu, Jarad M. Martin, Swetha Sridharan et al. · 2026 · The Lancet Oncology
93. Neck-to-height ratio is positively associated with diabetic kidney disease in Chinese patients with type 2 diabetes mellitus
    Zhiying He, Xiao Gu, Lin-Jia Du, Xiang Hu, Xingxing Zhang, Lijuan Yang, Yingqian Li, Jing Li, Lin-Yu Pan, Bo Yang et al. · 2023 · Frontiers in Endocrinology
94. Development and validation of the prediction model for mortality in patients with diabetic kidney disease in intensive care unit: a study based on medical information Mart for intensive care
    Wei Jin, Haijiao Jin, Xinyu Su, Miaolin Che, Qin Wang, Leyi Gu, Zhaohui Ni · 2023 · Renal Failure
95. Managing cardio-renal-metabolic risk in patients with type 2 diabetes: the role of finerenone
    Tiziana Filardi, Alessandra Feraco, Antoine Ouvrard‐Pascaud, Manfredi Rizzo, Massimiliano Caprio · 2024 · Journal of Diabetes and its Complications
96. Type 2 diabetes and chronic kidney disease as long‐term predictors of cardiovascular events in patients with coronary artery disease
    LAURA SCHNETZER, Andreas Leiherer, Andreas Festa, Axel Mündlein, THOMAS PLATTNER, Gert J. Mayer, Christoph H. Saely, Heinz Drexel · 2024 · European Journal of Clinical Investigation
97. Association between left atrial remodeling and early renal impairment in asymptomatic patients with type 2 diabetes
    Mingxia Gong, Min Xu, Suoya Pan, Xiaohong Jiang · 2025 · BMC Cardiovascular Disorders
98. Undiagnosed Depression among Hypertensive Individuals in Gaza: A Cross-sectional Survey from Palestine
    Khalid Jamal Khadoura, Elham Shakibazadeh, Mohammad Alì Mansournia, Yousef Ibrahim Aljeesh, Akbar Fotouhi · 2021 · Ethiopian Journal of Health Sciences
99. Contemporary Management of Stable Coronary Artery Disease ― Implications of the ISCHEMIA Trial ―
    Shun Kohsaka, Kenji Fukushima, Ippei Watanabe, Susumu Manabe, Nozomi Niimi, Yodo Gatate, Mitsuaki Sawano, Shintaro Nakano · 2021 · Circulation Journal
100. Examining the factors contributing to the association between non-albuminuric CKD and a low rate of kidney function decline in diabetes
     Oyunchimeg Buyadaa, Agus Salim, Jedidiah I Morton, Karin Agnes Maria Jandeleit-Dahm, Dianna J. Magliano, Jonathan E. Shaw · 2022 · Therapeutic Advances in Endocrinology and Metabolism